Investigation of the potential impact of benchmark dose and pharmacokinetic modeling in noncancer risk assessment

Journal of Toxicology and Environmental Health

Volumn 52, Issue 6, 1997, Pages 475-515

  Clewell, Harvey J ^a   Gentry, P Robinan ^a   Gearhart, Jeffery M ^a  

^a ICF INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DICHLOROMETHANE; TRICHLOROETHYLENE;

ARTICLE; DOSE RESPONSE; DOSIMETRY; HUMAN; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; TOXICITY TESTING; TOXICOKINETICS;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; METHYLENE CHLORIDE; MICE; MODELS, BIOLOGICAL; PHARMACOKINETICS; RISK ASSESSMENT; TOXICOLOGY; TRICHLOROETHYLENE;

EID: 0031587525     PISSN: 00984108     EISSN: None     Source Type: Journal    
DOI: 10.1080/00984109708984077     Document Type: Article

References (89)

1. Adams, E. M., Spencer, H. C., Rowe, V. K., McCollister, D. D., and Irish, D. D. 1952. Vapor toxicity of carbon tetrachloride determined by experiments on laboratory animals. Arch. Ind. Hyg. Occup. Med. 6:50-66.
2. Agency for Toxic Substances and Disease Registry. 1993. Toxicological Profile for Methylene Chloride. TP-92/13. Atlanta, Georgia: ATSDR.
3. Agency for Toxic Substances and Disease Registry. 1995. Toxicological Profile for Trichloro-ethylene. Draft for Public Comment. Atlanta, Georgia: ATSDR.
4. Al-Hachim, G. M. 1971. Effect of aldrin on the condition avoidance response and electroshock seizure threshold of offspring from aldrin-treated mother. Psychopharmacologia 21:370-373.
5. Al-Hachim, G. M., and Al-Baker, A. 1973. Effects of chlordane on conditioned avoidance response, brain seizure threshold and open-field performance of prenatally-treated mice. Br. j. Pharmacol. 49:311-315.
6. Allen, B., Kimmel, C., Kavlock, R., and Faustman, E. 1994. Dose-response assessment for development toxicity. II. Comparison of generic benchmark dose estimates with NOAELs. Fundam. Appl. Toxicol. 23:487-495.
7. Altmann, L., Bottger, A., and Wiegand, H. 1990. Neurophysiological and psychophysical measurements reveal effects of acute low-level organic solvent exposure in humans. Int. Arch. Occup. Environ. Health 62:493-499.
8. Andersen, M. E., Clewell, H. J., and Frederick, C. B. 1995a. Applying simulation modeling to problems in toxicology and risk assessment—A short perspective. Toxicol. Appl. Pharmacol. 133:181-187.
9. Andersen, M. E., Clewell, H. J., Gargas, M. I., Smith, F. A., and Reitz, R. H. 1987. Physiologically based pharmacokinetics and the risk assessment process for methylene chloride. Toxicol. Appl. Pharmacol. 87:185-205.
10. Andersen, M. E., Clewell, H. J., and Krishnan, K. 1995b. Tissue dosimetry, pharmacokinetic modeling, and interspecies scaling factors. Risk Anal. 15:533-537.
11. Andersen, M. E., Gearhart, J. M., and Clewell, H. J. 1995c. Development and preliminary evaluation of physiologically-based pharmacokinetic models for non-cancer risk assessments with elemental and inorganic mercury. ICF Kaiser Engineers report to EPA/OHEA and OSHA/ DHSP.
12. Arito, H., Takahashi, M., and Ishikawa, T. 1994. Effect of subchronic inhalation exposure to low-level trichloroethylene on heart rate and wakefulness-sleep in freely moving rats. jpn. I. Ind. Health 36:1-8.
13. Beck, B. D., Conolly, R. B., Dourson, M. L., Guth, D., Hattis, D., Kimmel, C., and Lewis, S. C. 1993. Improvements in quantitative noncancer risk assessment. Fundam. Appl. Toxicol. 20:1-14.
14. Bruckner, J. V., Mackenzie, W. F., Muralidhara, S., Luthra, R., Kyle, G. M., and Acosta, D. 1986. Oral toxicity of carbon tetrachloride: acute, subacute, and subchronic studies in rats. Fundam. Appl. Toxicol. 6:16-34.
15. Burt, C. S. 1975. Use of behavioral techniques in the assessment of environmental contaminants. In Behavioral toxicology, eds. B. Weiss and V. G. Laties, pp. 241-263. New York: Plenum Press.
16. Buser, S., Droz, P. O., and Vahter, M. 1994. A Physiologically Based Pharmacokinetic Model for Arsenic Exposure. Final Report prepared for the Electrical Power Research Institute, Palo Alto, CA.
17. Clewell, H. J. 1995a. The use of physiologically based pharmacokinetic modeling in risk assessment: A case study with methylene chloride. In Low-dose extrapolation of cancer risks: Issues and perspectives, eds. S. Olin, W. Farland, C. Park, L. Rhomberg, R. Scheuplein, T. Starr, and). Wilson, pp. 199-221. Washington, DC: ILSI Press.
18. Clewell, H. J. 1995b. The application of physiologically based pharmacokinetic modeling in human health risk assessment of hazardous substances. Toxicol. Lett. 79:207-217.
19. Clewell, H.)., and Andersen, M. E. 1985. Risk assessment extrapolations and physiological modeling. Toxicol. Ind. Health 1:4:111-131.
20. Clewell, H. J., and Andersen, M. E. 1989. Biologically motivated models for chemical risk assessment. Health Phys. 57(suppl. 1): 129-137.
21. Clewell, H. J., and Jarnot, B. M. 1994. Incorporation of pharmacokinetics in non-carcinogenic risk assessment: Example with chloropentafluorobenzene. Risk Anal. 14:265-276.
22. Clewell, H. J., Gentry, P. R., Gearhart, J. M., and Allen, B. C. 1994. Evaluation of Pharmacokinetic Models for Use in Quantitative Risk Assessment: Example with Trichloroethylene. ICF Kaiser International report to OSHA/DHSP and EPA/OF1EA.
23. Clewell, H. J., Gentry, P. R., Gearhart, J. M., Allen, B. C., Covington, T. R., and Andersen, M E. 1995a. Applying Mechanistic Information, Pharmacokinetic Modeling and Margin of Exposure Evaluations in a Novel Risk Assessment for Trichloroethylene and Its Active Carcinogenic Metabolites: Chloral Hydrate, Trichloroacetic Acid, Dichloroacetic Acid, and Dichlorovinylcysteine. ICF Kaiser International report to EPA/OHEA and OSHA/DHSP.
24. Clewell, H. J., Covington, T. R., Crump, K. S., and Andersen, M. E. 1995b. The Application of a Physiologically-Based Pharmacokinetic Model for Vinyl Chloride in a Noncancer Risk Assessment. ICF Kaiser International report to EPA/ECAO.
25. Clewell, H. J., Gentry, P. R., Gearhart, J. M., Allen, B. C., and Andersen, M. E. 1995c. The Development and Validation of a Physiologically Based Pharmacokinetic Model for Vinyl Chloride and Its Application in a Carcinogenic Risk Assessment for Vinyl Chloride. ICF Kaiser International report to EPA/OHEA and OSHA/DHSP.
26. Corley, R. B, Mendrala, A. M., Gargas, M. L., Andersen, M. E., Conolly, R. B., Staats, D., and Reitz, R. H. 1990. Development of a physiologically based pharmacokinetic model for chloroform. Toxicol. Appl. Pharmacol. 103:512.
27. Crump, K. 1984. A new method for determining allowable daily intakes. Fundam. Appl. Toxicol. 4:854-871.
28. Crump, K. 1995. Calculation of benchmark doses from continuous data. Risk Anal. 15:79-89.
29. David, A., Frantik, E., Holusa, R., and Novakova, O. 1981. Role of time and concentration on carbon tetrachloride toxicity in rats. Int. Arch. Occup. Environ. Health 48:49-60.
30. Dawson, B. V., Johnson, P. D., Goldberg, S. J., and Ulreich, J. B. 1993. Cardiac teratogenesis of halogenated hydrocarbon-contaminated water .j. Am. Coll. Cardiol. 21:1466-1472.
31. Dieter, M. P., Boorman, G. A., Jameson, C. W., Eustis, S. L., and Uraih, L. C. 1992. Development of renal toxicity in F344 rats gavaged with mercuric chloride for 2 weeks, or 2,4,6,15, and 24 months. J. Toxicol. Environ. Health 36:319-340.
32. D'Souza, R. W., and Boxenbaum, H. 1988. Physiological pharmacokinetic models: Some aspects of theory, practice and potential. Toxicol. Ind. Health 4:2:151-171.
33. Eriksson, P., and Nordberg, A. 1986. The effects of DDT, DDOH-palmitic acid, and a chlorinated paraffin on muscarinic receptors and the sodium-dependent choline uptake in the central nervous system of immature mice. Toxicol. Appl. Pharmacol. 85:121-127.
34. Eriksson, P., Archer, T., and Fredriksson, A. 1990. Altered behaviour in adult mice exposed to a single low dose of DDT and its fatty acid conjugate as neonates. Brain Res. 514:141-142.
35. Eriksson, P., Archer, I., and Fredriksson, A. 1992. Exposure to DDT during a defined period in neonatal life induces permanent changes in brain muscarinic receptors and behaviour in adult mice. Brain Res. 582:277-281.
36. Eriksson, P., Johansson, U., Ahlbom, J., and Fredriksson, A. 1993. Neonatal exposure to DDT induces increased susceptibility to pyrethroid (bioallethrin) exposure at adult age. Changes in cholinergic muscarinic receptor and behavioural variables. Toxicology 77:21-30.
37. Eriksson, P., Nilsson-Hakansson, L., Nordberg, A., Aspberg, A., and Fredriksson, A. 1990b. Neonatal exposure to DDT and its fatty acid conjugate: Effects on cholinergic and behavioural variables in the adult mouse. NeuroToxicology 11:345-354.
38. Fawer, R. F., De Ribaupierre, Y., Guillemin, M. P., Berode, M., and Lob, M. 1983. Measurement of hand tremor induced by industrial exposure to metallic mercury. Br. J. Ind. Med. 40:204-208.
39. Ferroni, C., Selis, L., Mutti, A., Folli, D., Bergamaschi, E., and Franchini, I. 1992. Neuro-behavioral and neuroendocrine effects of occupational exposure to perchloroethylene. NeuroToxicology 13:243-248.
40. Fitzhugh, O. G., and Nelson, A. A. 1947. The chronic oral toxicity of DDT (2,2-bis-(p-chlorophenyl-1,1,1-trichloroethane).J. Pharmacol. Exp. Ther. 89:18-30.
41. Fitzhugh, O. G., Nelson, A. A., and Quaife, M. L. 1964. Chronic oral toxicity of aldrin and dieldrin in rats and dogs. Food Cosmet. Toxicol. 2:551-562.
42. Frederick, C. B., Potter, D. W., Chang-Mateu, M. I., and Andersen, M. E. 1992. A physiologically based pharmacokinetic and pharmacodynamic model to describe the oral dosing of rats with ethyl acrylate and its implications for risk assessment. Toxicol. Appl. Pharmacol. 114:246-260.
43. Fredriksson, A., Dahlgren, L., Danielsson, B., Eriksson, P., Dencker, L., and Archer, T. 1992. Behavioural effects of neonatal metallic mercury exposure in rats. Toxicology 74:151-160.
44. Fredriksson, A., Danielsson, B., and Eriksson, P. 1993. Altered behaviour in adult mice orally exposed to tri- and tetrachloroethylene as neonates. Toxicol. Lett. 66:13-19.
45. Gaylor, D. W., and Slikker, W. 1990. Risk assessment for neurotoxic effects. NeuroToxicology 11:211-218.
46. Gearhart, J. M., Mahle, D. A., Greene, R. J., Seckel, C. S., Flemming, C. D., Fisher, J. W., and Clewell, H. J. 1993. Variability of physiologically-based pharmacokinetic (PB-PK) model parameters and their effects on PB-PK model predictions in a risk assessment for perchloroethylene. Toxicol. Lett. 68:131-144.
47. Gearhart, J., Haber, L., and Allen, B. 1995a. The Development of a Toxicokinetic Model for Predicting Adverse Effects Occurring from Inhalation Exposure to Cadmium. ICF Kaiser International report to EPA/ECAO.
48. Gearhart, J. M., Clewell, H. J., Crump, K. S., Shipp, A. M., and Silvers, A. 1995b. Pharmacokinetic dose estimates of mercury in children and dose-response curves of performance tests in a large epidemiological study. Water Air Soil Pollut. 80:49-58.
49. Gerlowski, L. E., and Jain, R. K. 1983. Physiologically based pharmacokinetic modeling: Principles and applications. J Pharm. Sci. 72:1103-1126.
50. Gerrity, T. R., and Henry, C. J. 1990. Principles of route-to-route extrapolation for risk assessment. New York: Elsevier.
51. Hake, C. L., and Stewart, R. D. 1977. Human exposure to tetrachloroethylene: Inhalation and skin contact. Environ. Health Perspect. 21:231-238.
52. Haun, C. C., Vernot, E. H., Darmer, L. I., and Diamond, S. S. 1972. Continuous animal exposure to low levels of dichloromethane. AMRL-TR-72-130. Proc. 3rd Ann. Conf. Environmental Toxicology, Aerospace Medical Research Laboratory, Aerospace Medical Division, Wright Patterson Air Force Base, OH.
53. Heywood, R., Sortwell, R. J., Noel, P. R. B., Street, A. E., Prentice, D. E., Roe, F. J. C, Wadsworth, P. F., and Worden, A. N. 1979. Safety evaluation of toothpaste containing chloroform. III. Long-term study in beagle dogs. J. Environ. Pathol. Toxicol. 2:835-851.
54. Himmelstein, K. J., and Lutz, R. J. 1979. A review of the application of physiologically based pharmacokinetic modeling. J. Pharmacokinet. Biopharm. 7:127-145.
55. Isaacson, L. G., and Taylor, D. H. 1989. Maternal exposure to 1,1,2-trichloroethylene affects myelin in the hippocampal formation of the developing rat. Brain Res. 488:403-407.
56. Khasawinah, A. M., and Grutsch, J. F. 1989. Chlordane: thirty-month tumorigenicity and chronic toxicity test in rats. Regul. Toxicol. Pharmacol. 10:95-109.
57. Khasawinah, A. M., Hardy, C. J., and Clark, G. C. 1989. Comparative inhalation toxicity of technical chlordane in rats and monkeys. J. Toxicol. Environ. Health 28:327-347.
58. Kjellstrom, T., and Nordberg, G. F. 1978. A kinetic model of cadmium metabolism in the human being. Environ. Res. 16:248-269.
59. Kjellstrom, T., and Nordberg, G. F. 1985. Kinetic model of cadmium metabolism. In Cadmium and health: A toxicological and epidemiological appraisal, Vol. 1, Exposure, dose, and metabolism, eds. L. Friberg, E.-G. Elinder, T. Kjellstrom, and G. F. Nordberg, pp. 179-197. Boca Raton, FL: CRC Press.
60. Larson, J. L., Wolf, D. C., Morgan, K. T., Mery, S., and Butterworth, B. E. 1994a. The toxicity of 1-week exposures to inhaled chloroform in female B6C3F1 mice and male F-344 rats. Fundam. Appl. Toxicol. 22:431-446.
61. Larson, J. L., Wolf, D. C., and Butterworth, B. E. 1994b. Induced cytotoxicity and cell proliferation in the hepatocarcinogenicity of chloroform in female B6C3F1 mice: Comparison of administration by gavage in corn oil vs ad libitum in drinking water. Fundam. Appl. Toxicol. 22:90-102.
62. Laug, E. P., Nelson, A. A., Fitzhugh, O. G., and Kunze, F. M. 1950. Liver cell alteration and DDT storage in the fat of the rat induced by dietary levels of 1 to 50 ppm DDT. J. Pharmacol. Exp. Ther. 98:268-273.
63. Leung, H. W. 1991. Development and utilization of physiologically based pharmacokinetic models for toxicological applications. J Toxicol. Environ. Health 32:247-267.
64. Lindstrom, F. T., Gillett, J. W., and Rodecap, S. E. 1974. Distribution of HEOD (dieldrin) in mammals: I. Preliminary model. Arch. Environ. Contam. Toxicol. 2:9-21.
65. Loose, L. D., Silkworth, J. B., Charbonneau, T., and Blumenstock, F. 1981. Environmental chemical-induced macrophage dysfunction. Environ. Health Perspect. 49:79-91.
66. MacEwen, J. D., Vernot, E. H., and Haun, C. C. 1972. Continuous Animal Exposure to Dichloromethane. AMRL-TR-72-28. Joint NASA/USAF Study. Wright Patterson Air Force Base, OH: Aerospace Medical Research Laboratory, Aerospace Medical Division.
67. Mann, S., Droz, P. O., and Vahter, M. 1996. A physiologically based pharmacokinetic model for arsenic exposure. I. Development in hamsters and rabbits. Toxicol. Appl. Pharmacol. 137:822.
68. Mumtaz, M. M., Sipes, I. G., Clewell, H. J., and Yang, R. S. H. 1993. Risk assessment of chemical mixtures: Biological and toxicologic issues. Fundam. Appl. Toxicol. 21:258-269.
69. National Cancer Institute. 1978. Bioassay of Dieldrin for Possible Carcinogenicity. DHEW Publication No. 78-822. Bethesda, MD: National Cancer Institute.
70. National Toxicology Program. 1993. Toxicology and Carcinogenesis Studies of Mercuric Chloride (CAS NO. 7487-97-7) in F344 Rats and B6C3F1 Mice (Gavage Studies). NTP TR 408. Research Triangle Park, NC: National Toxicology Program.
71. National Research Council. 1987. Pharmacokinetics in risk assessment. Drinking water and health, Vol. 8. Washington, DC: National Academy Press.
72. Nogawa, K., Honda, R., Kido, T., Tsubitani, I., Yamada, Y., Ishizaki, M., and Yamaya, H. 1989. A dose-response analysis of cadmium in the general environment with special reference to total cadmium intake limit. Environ. Res. 48:7-16.
73. Oberdorster, G. 1989. Deposition and retention modeling of inhaled cadmium in rat and human lung: an example for extrapolation of effects and risk estimation. In Extrapolation of dosimetric relationships for inhaled particles and gases, eds. J. D. Crapo, E. D. Smolko, F. J. Miller, J. A. Graham, and A. W. Hayes, pp. 345-370. San Diego: Academic Press.
74. Oberdorster, G. 1990. Equivalent oral and inhalation exposure to cadmium compounds: Risk estimation based on route-to-route extrapolation. In Principles of route-to-route extrapolation for risk assessment, eds. T. R. Gerrity and C. J. Henry, pp. 217-235. New York: Elsevier.
75. Ortega, P., Hayes, W. J., and Durham, W. F. 1957. Pathologic changes in the liver of rats after feeding low levels of various insecticides. Arch. Pathol. 64:614-622.
76. Paustenbach, D. J., Clewell, H. J., Gargas, M. L, and Andersen, M. E. 1988. A physiologically- based pharmacokinetic model for carbon tetrachloride. Toxicol. Appl. Pharmacol. 96:191-211.
77. Phoon, W. H., Goh, K. T., Lee, L. T., Tan, K. T., and Kwok, S. F. 1983. Toxic jaundice from occupational exposure to chloroform. Med. I. Malaysia 38:31-34.
78. Reitz, R. H., McDougal, J. N., Himmelstein, M. W., Nolan, R. J., and Schumann, A. M. 1988.Physiologically based pharmacokinetic modeling with methylchloroform: Implications for interspecies, high dose/low dose, and dose route extrapolations. Toxicol. Appl. Pharmacol. 95:185-199.
79. Reitz, R. H., Mendrala, A. L., Corley, R. A., Quast, J. F., Gargas, M. L., Andersen, M. E., Staats, D. A., and Conolly, R. B. 1990. Estimating the risk of liver cancer associated with human exposures to chloroform using physiologically based pharmacokinetic modeling. Toxicol. Appl. Pharmacol. 105:443.
80. Schwetz, B. A., Leong, G. K. J., and Gehring, P. J. 1974. Embryo- and fetotoxicity of inhaled chloroform in rats. Toxicol. Appl. Pharmacol. 28:442-451.
81. Serota, D. G., Thakur, A. K., Ulland, B. M., Kirschman, J. C., Brown, N. M., and Coots, R. H. 1986. A two-year drinking-water study of dichloromethane in rodents. Food Chem. Toxicol. 24:951-958.
82. Smialowicz, R. J., Simmons, J. E., Luebke, R. W., and Allis, J. W. 1991. Immunotoxicologic assessment of subacute exposure of rats to carbon tetrachloride with comparison to hepato-toxicity and nephrotoxicity. Fundam. Appl. Toxicol. 17:186-196.
83. Stewart, R. D., Dodd, H. C., Gay, H. H., and Erley, D. S. 1970. Experimental human exposure to trichloroethylene. Arch. Environ. Health 20:64-70.
84. Tseng, W. P. 1977. Effects and dose-response relationships of skin cancer and blackfoot disease with arsenic. Environ. Health Perspect. 19:109-119.
85. Tseng, W. P., Chu, H. M., How, S. W., and Fong, J. M. 1968. Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J. Natl. Cancer Inst. 40:453-463.
86. U.S. Environmental Protection Agency. 1989. Biological Data for Pharmacokinetic Modeling and Risk Assessment. EPA/600/3-90/019. Washington, DC: U.S. EPA.
87. U.S. Environmental Protection Agency. 1994. Methods for derivation of inhalation reference concentrations and application of inhalation dosimetry. EPA/600/8-90/066F. Washington, DC: Office of Health and Environmental Assessment.
88. Walker, A. I. T., Stevenson, D. E., Robinson, J., Thorpe, E., and Roberts, M. 1969. The toxicology and pharmacodynamics of dieldrin (HEOD): Two-year oral exposures of rats and dots. Toxicol. Appl. Pharmacol. 15:345-373.
89. Winneke, G. 1974. Behavioral effects of methylene chloride and carbon monoxide assessed by sensory and psychomotor performance. In Behavioral toxicology, eds. C. Xintaras and D. L. Johnson, pp. 130-144. Washington, DC: U.S. Department of Health, Education, and Welfare.